Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent - A case report
dc.authorid | Sevinç, Alper/0000-0002-0499-8918; | |
dc.authorwosid | Sevinc, Alper/KFQ-6440-2024 | |
dc.authorwosid | Sevinç, Alper/KPA-4519-2024 | |
dc.authorwosid | Sari, Ramazan/C-2868-2016 | |
dc.contributor.author | Sari, R | |
dc.contributor.author | Sevinc, A | |
dc.contributor.author | Buyukberber, S | |
dc.date.accessioned | 2024-08-04T20:12:08Z | |
dc.date.available | 2024-08-04T20:12:08Z | |
dc.date.issued | 2000 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Ticlopidine is an oral antiplatelet agent frequently utilized in the treatment of cerebrovascular disease. It is rarely associated with severe bone marrow suppression. A case of an elderly woman is reported who developed febrile agranulocytosis two months after commencing ticlopidine but who had a favorable outcome after cessation of that drug and treatment with granulocyte colony-stimulating factor (G-CSF). All patients should have regular monitoring of their blood counts during therapy with ticlopidine. | en_US |
dc.identifier.doi | 10.1177/000331970005100707 | |
dc.identifier.endpage | 593 | en_US |
dc.identifier.issn | 0003-3197 | |
dc.identifier.issue | 7 | en_US |
dc.identifier.pmid | 10917583 | en_US |
dc.identifier.scopus | 2-s2.0-0033941163 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.startpage | 591 | en_US |
dc.identifier.uri | https://doi.org/10.1177/000331970005100707 | |
dc.identifier.uri | https://hdl.handle.net/11616/93237 | |
dc.identifier.volume | 51 | en_US |
dc.identifier.wos | WOS:000088277700007 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Westminster Publ Inc | en_US |
dc.relation.ispartof | Angiology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Severe Aplastic-Anemia | en_US |
dc.subject | Mechanism | en_US |
dc.subject | Therapy | en_US |
dc.title | Ticlopidine-induced severe agranulocytosis after the placement of coronary artery stent - A case report | en_US |
dc.type | Article | en_US |